Indivior Pact Buys Addex Time For Progressing Dipraglurant And Pipeline

 
• By Sten Stovall

Addex Therapeutics says its licensing deal with Indivior to develop and commercialize its investigative addiction therapy ADX71441 'buys time' to find resources for progressing its own pipeline.

Steps
Addex To Use Indivior Drug Deal To Help Advance To Next Platform Stages • Source: Shutterstock

More from Business

More from Scrip